Community Programs for Clinical Research on AIDS: Difference between revisions

Revision as of 16:17, 21 April 2016

Revision as of 16:22, 21 April 2016

Line 8:

The '''Community Programs for Clinical Research on AIDS''' (CPCRA) was a programme sponsored by [[National Institutes of Health]] (NIH).<ref>[http://link.springer.com/article/10.1007%2FBF01964462]</ref>

The CPCRA was established in 1989<ref>{{cite web |url=https://aspe.hhs.gov/report/inventory-federally-sponsored-hiv-and-hiv-relevant-databases/database-terry-beirn-community-programs-clinical-research-aids-cpcra-observational-data-base-odb |title=An inventory of federally sponsored HIV and HIV-relevant databases. Database:Terry Beirn community programs for clinical research on AIDS (CPCRA) observational database (ODB) |publisher=ASPE |date=7 January 2000 |accessdate=21 April 2016}}</ref> and includes 15 research units. A Statistical Center at the [[University of MissesotaMinnesota]] was funded from 1990 to 1997.<ref>[http://grantome.com/grant/NIH/N01-AI005073-017 research grant information]</ref><ref>[http://www.rdatlas.com/portal/portal.cfm?page=grants&applicationid=2296440]</ref>

According to the CPCRA's own website, they were :

Line 14:

"an experienced community-based clinical trials network whose main goal is to obtain evidence to properly inform healthcare providers and people living with [[HIV]] on the most appropriate use of available HIV therapies in diverse populations across the spectrum of HIV diseases..."<ref>[http://cpcra.s-3.com/]</ref>

The overall objective of the CPCRA is to design studies of sufficient size and duration of follow up to evaluate the long-term benefits and [[unintended consequence]]s of various treatment strategies using available agents to assess long-term immunologic, virologic and clinical outcomes. CPCRA trials are designed with nested substudies aimed at understanding the pathogenesis of HIV infection and the public health implications of its treatment. <ref>[http://www.niaid.nih.gov/DAIDs/pdatguide/cpcra.htm]{{dead link|date=April 2016}}</ref>

The CPCRA was established in 1989 and includes 15 research units.

The overall objective of the CPCRA is to design studies of sufficient size and duration of follow up to evaluate the long-term benefits and [[unintended consequence]]s of various treatment strategies using available agents to assess long-term immunologic, virologic and clinical outcomes. CPCRA trials are designed with nested substudies aimed at understanding the pathogenesis of HIV infection and the public health implications of its treatment. <ref>[http://www.niaid.nih.gov/DAIDs/pdatguide/cpcra.htm]{{dead link|date=April 2016}}</ref>

==References==